Evidence map›Paper›PMID 33489040›Full record

ArticleMediterranean journal of hematology and infectious diseases2021

Detection of Common Deletional of α-Thalassemia 3.7 Kb from Metropolitan Region of Manaus, Amazonas, Brazil.

Fernanda Cozendey Anselmo, Abdou Gafar Soumanou, Cleidiane de Aguiar Ferreira, Flora Maia Viga Sobrinha, Ana Caroline Santos Castro, Rafael Oliveira Brito, Adolfo José da Mota, Marilda de Souza Gonçalves, José Pereira de Moura Neto

Open access · goldAbstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Fernanda Cozendey AnselmoUniversidade do Estado do Amazonas - Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Amazonas, Brasil.
Abdou Gafar SoumanouUniversidade Federal do Amazonas, Faculdade de Ciências Farmacêuticas, Manaus, Amazonas, Brasil.
Cleidiane de Aguiar FerreiraSecretaria do Estado do Amazonas - SUSAM.
Flora Maia Viga SobrinhaSecretaria do Estado do Amazonas - SUSAM.
Ana Caroline Santos CastroUniversidade Federal do Amazonas, Faculdade de Ciências Farmacêuticas, Manaus, Amazonas, Brasil.
Rafael Oliveira BritoUniversidade Federal do Amazonas, Faculdade de Ciências Farmacêuticas, Manaus, Amazonas, Brasil.
Adolfo José da MotaUniversidade Federal do Amazonas, Faculdade de Ciências Farmacêuticas, Manaus, Amazonas, Brasil.
Marilda de Souza GonçalvesFundação Oswaldo Cruz - Centro de Pesquisas Gonçalo Moniz, Salvador, Bahia, Brasil.
José Pereira de Moura NetoUniversidade do Estado do Amazonas - Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas, Manaus, Amazonas, Brasil.
Universidade Federal do Amazonas · BRFundação Hospitalar de Hematologia e Hemoterapia do Amazonas · BRFundação de Amparo à Pesquisa do Estado da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlpha Thalassemia (α-thal) is a heterogeneous group of hereditary alterations caused by deletions that affect alpha regulatory genes, and the 3.7Kb deletion is the most frequent worldwide. The prevalence ranges from 20% and 35% in Brazil, depending mainly on race, predominant in Afro-descendants. PURPOSE: The aim was to determine α-thal -

methodsVolunteers age between 18-59 years old of both genders participated in the study. Blood was collected from March 2014 to September 2017 at the health centers of each participant city. α-thal

resultsThe average age among males was 35.3±14.8, while for females, it was 36.7±14.9 years old. Microcytosis (MCV <80fL) was found in 158 individuals (8,46%) and α-thal diagnosed in 143 individuals (7.9%), and all of these individuals carried the

conclusionThis study highlights α-thal 3.7kb deletion as an important public health problem, especially in a population not yet characterized about this disease. Thus, epidemiological studies using molecular tools become relevant in regions where the disease is underestimated, contributing to a better understanding of thalassemia incidence and iron deficiency anemias incidence of the participating cities. We reinforce that future molecular studies in North Region from Brazil can be utilized to describe other genetic anemias as structural hemoglobinopathies that have already proven to be highly prevalent in Brazil.

Indexed as

Alpha ThalassemiaAmazonasBrazilIron Treatment

Identifiers

PMID33489040
PMCPMC7813276
OpenAlexW3118912057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.